**Abstract**

**Introduction:** According to DSM5 (1) panic disorder (PD) is a unitary diagnosis, however, recent studies point to distinct PD subtypes. The respiratory subtype (RS) is the most studied subtype and there is abundant evidence of its validity. (2, 3) Compared to non-respiratory subtype (NRS) patients the RS patients have more psychiatric comorbidities, more familial history of PD and higher sensitivity to carbon dioxide, hyperventilation and caffeine. (2--5)

**Objectives:** Ascertain if RS patients have a more severe form of PD and respond poorly to pharmacological treatment, compared to NRS patients.

**Methods:** 60 PD patients without treatment were recruited for the current study. Clinical evaluation and administration of scales and questionnaires were made in the first hospital visit. The clinicians chose the medications freely and started the treatment, after 4 weeks doses were adjusted and medications were switched if necessary. All subjects were evaluated again with the same instruments after 8 weeks of treatment. The instruments used were: Mini International Neuropsychiatric Interview (MINI)(6); Panic and Agoraphobia Scale (PAS)(7); Clinical Global Impression - severity and improvement (CGI-S and CGI-I)(8); Beck Anxiety Inventory (BAI)(9); Beck Depression Inventory (BDI)(10); Diagnostic Symptom Questionnaire (DSQ)(11).

**Results:** Only 33 patients concluded the study. In baseline RS patients had more comorbidities with agoraphobia (P= 0.02), higher scores in PAS (P= 0.03), BAI (P\< 0.01), BDI (P= 0.05) and DSQ (P\< 0.01), compared to NRS patients. In the comparison between baseline and 8-week evaluations, with all patients, there were significant improvements in CGI-S, PAS, BAI and BDI (all with P\< 0.01). 56.4% of the patients responded to treatment. There were no statistically significant differences between RS and NRS regarding the improvement and response to treatment.

**Conclusion:** RS patients presented initially a more severe form of PD, but they had a good response to treatment, indistinguishable from the response of NRS patients.
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